222 related articles for article (PubMed ID: 33589411)
21. Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation.
Gmeiner JMD; Linnemann M; Steffen J; Scherer C; Orban M; Theiss H; Mehilli J; Sadoni S; Peterß S; Joskowiak D; Hagl C; Tsilimparis N; Curta A; Maurus S; Doldi PM; Löw K; Haum M; Roden D; Hausleiter J; Massberg S; Rizas K; Deseive S; Braun D
EuroIntervention; 2022 Nov; 18(10):812-819. PubMed ID: 35903846
[TBL] [Abstract][Full Text] [Related]
22. A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study.
Rosseel L; Montarello NJ; Nuyens P; Tirado-Conte G; Quagliana A; Cornelis K; Floré V; Rosseel M; Bieliauskas G; Sondergaard L; De Backer O
EuroIntervention; 2024 Mar; 20(6):e354-e362. PubMed ID: 37982158
[TBL] [Abstract][Full Text] [Related]
23. Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
Reifart J; Liebetrau C; Weferling M; Dörr O; Renker M; Bhumimuang K; Liakopoulos O; Choi YH; Nef H; Hamm CW; Kim WK
Int J Cardiol; 2021 May; 331():183-188. PubMed ID: 33529662
[TBL] [Abstract][Full Text] [Related]
24. Transubclavian approach: A competitive access for transcatheter aortic valve implantation as compared to transfemoral.
Amat-Santos IJ; Rojas P; Gutiérrez H; Vera S; Castrodeza J; Tobar J; Goncalves-Ramirez LR; Carrasco M; Catala P; San Román JA
Catheter Cardiovasc Interv; 2018 Nov; 92(5):935-944. PubMed ID: 29314570
[TBL] [Abstract][Full Text] [Related]
25. A "double crossover technique" in an obese patient undergoing transfemoral transcatheter aortic valve implantation: How to accomplish hemostasis percutaneously?
Onishi H; Naganuma T; Nakamura S
Cardiovasc Revasc Med; 2017 Sep; 18(6):440-444. PubMed ID: 28941480
[TBL] [Abstract][Full Text] [Related]
26. Totally Percutaneous Transfemoral Transcatheter Aortic Valve Replacement Despite Failure to Deploy a Vascular Closure Device: A Single-Centre Case Series.
Eitan A; Shiran A; Sliman H; Zafrir B; Jaffe R
Heart Lung Circ; 2022 Mar; 31(3):390-394. PubMed ID: 34607752
[TBL] [Abstract][Full Text] [Related]
27. Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
Barbash IM; Wasserstrum Y; Erlebach M; Guetta V; Ziegelmüller J; Segev A; Fefer P; Maor E; Lange R; Ruge H
Catheter Cardiovasc Interv; 2024 Jan; 103(1):160-168. PubMed ID: 38059295
[TBL] [Abstract][Full Text] [Related]
28. Comparison of a Single Versus Double Perclose Technique for Percutaneous Transfemoral Transcatheter Aortic Valve Replacement.
Phan DQ; Qattan M; Lee MS; Zadegan R; Mansukhani P; Brar SS; Aharonian V; Moore N
J Invasive Cardiol; 2021 Jul; 33(7):E540-E548. PubMed ID: 34224383
[TBL] [Abstract][Full Text] [Related]
29. Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis.
Sedhom R; Dang AT; Elwagdy A; Megaly M; Elgendy IY; Zahr F; Gafoor S; Mamas M; Elbadawi A
Catheter Cardiovasc Interv; 2023 Mar; 101(4):817-827. PubMed ID: 36802100
[TBL] [Abstract][Full Text] [Related]
30. Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation.
Barbash IM; Barbanti M; Webb J; Molina-Martin De Nicolas J; Abramowitz Y; Latib A; Nguyen C; Deuschl F; Segev A; Sideris K; Buccheri S; Simonato M; Rosa FD; Tamburino C; Jilaihawi H; Miyazaki T; Himbert D; Schofer N; Guetta V; Bleiziffer S; Tchetche D; Immè S; Makkar RR; Vahanian A; Treede H; Lange R; Colombo A; Dvir D
Eur Heart J; 2015 Dec; 36(47):3370-9. PubMed ID: 26314688
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis.
Villecourt A; Faroux L; Muneaux A; Tassan-Mangina S; Heroguelle V; Poncet A; Nazeyrollas P; Ruggieri VG; Metz D
Arch Cardiovasc Dis; 2020 Mar; 113(3):189-198. PubMed ID: 32037133
[TBL] [Abstract][Full Text] [Related]
32. Comparison of MANTA vs ProGlide Vascular Closure Device and 30-Day Outcomes in Transfemoral Transcatheter Aortic Valve Implantation.
Eftychiou C; Eteocleous N; Mitsis A; Zittis I; Papadopoulos K; Petrou A; Adamou M; Kounnos C; Bekos C; Avraamides P
Tex Heart Inst J; 2022 Sep; 49(5):. PubMed ID: 36269884
[TBL] [Abstract][Full Text] [Related]
33. Carotid versus femoral access for transcatheter aortic valve implantation: a propensity score inverse probability weighting study.
Folliguet TA; Teiger E; Beurtheret S; Modine T; Lefevre T; Van Belle E; Gilard M; Eltchaninoff H; Koning R; Iung B; Verhoye JP; Leprince P; Le Breton H; Lafont A; Parolari A; Barili F
Eur J Cardiothorac Surg; 2019 Dec; 56(6):1140-1146. PubMed ID: 31365061
[TBL] [Abstract][Full Text] [Related]
34. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.
Swift SL; Puehler T; Misso K; Lang SH; Forbes C; Kleijnen J; Danner M; Kuhn C; Haneya A; Seoudy H; Cremer J; Frey N; Lutter G; Wolff R; Scheibler F; Wehkamp K; Frank D
BMJ Open; 2021 Dec; 11(12):e054222. PubMed ID: 34873012
[TBL] [Abstract][Full Text] [Related]
35. Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths.
Ando T; Takagi H; Grines CL
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):484-492. PubMed ID: 28549125
[TBL] [Abstract][Full Text] [Related]
36. Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry.
Honda Y; Yamawaki M; Nakano T; Makino K; Ito Y; Yashima F; Tada N; Naganuma T; Yamanaka F; Mizutani K; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Shirai S; Hayashida K;
Cardiovasc Revasc Med; 2022 May; 38():11-18. PubMed ID: 34391679
[TBL] [Abstract][Full Text] [Related]
37. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
[TBL] [Abstract][Full Text] [Related]
38. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
[TBL] [Abstract][Full Text] [Related]
39. Vascular access site complications after transfemoral transcatheter aortic valve implantation in the POL-TAVI Registry: surgical versus percutaneous approach.
Walas RL; Kukulski L; Rychter J; Jaźwiec T; Gąska M; Hawranek M; Zembala M; Gąsior M; Zembala MO
J Cardiovasc Surg (Torino); 2020 Feb; 61(1):117-122. PubMed ID: 31815374
[TBL] [Abstract][Full Text] [Related]
40. Transradial Secondary Access to Guide Valve Implantation and Manage Peripheral Vascular Complications During Transcatheter Aortic Valve Implantation.
Jackson MWP; Muir DF; de Belder MA; Palmer S; Owens WA; Goodwin A; Hayat U; Williams PD
Heart Lung Circ; 2019 Apr; 28(4):637-646. PubMed ID: 29685717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
